Advertisement

Nevi (Benign Melanocytic)

  • Alexander C. KatoulisEmail author
  • Dimitrios Sgouros
  • Nikolaos G. Stavrianeas

Abstract

Melanocytic nevi are benign hamartomas of the skin composed of nevus cells. They are almost always present in fair-skinned individuals and can arise in any anatomic site. When present at birth or during the first 2 years of life, they are categorized as congenital nevi. Melanocytic nevi that show up later in life are described as acquired nevi. The latter are further classified into common acquired nevus, dysplastic (atypical) nevus, blue nevus, Spitz nevus, and halo nevus. Their association with melanoma seems to depend on the total number and the specific types of melanocytic nevi. Regarding their benign nature, usually they do not require any therapeutic intervention. However nevi at special anatomic sites, atypical nevi, or nevi with an intriguing clinical-dermoscopic presentation should be followed up with dermoscopy in a more regular basis.

Keywords

Common acquired melanocytic nevi Congenital melanocytic nevi Blue nevus Halo nevus Dysplastic nevus Atypical nevus Spitz nevus Malignant melanoma Dermoscopy Histopathology 

Further Reading

  1. Ackerman AB, Milde P. Naming acquired melanocytic nevi. Common and dysplastic, normal and atypical, or Unna, Miescher, Spitz, and Clark? Am J Dermatopathol. 1992;14:447–53.CrossRefGoogle Scholar
  2. Alikhan A, Ibrahimi OA, Eisen DB. Congenital melanocytic nevi: where are we now? Part I. Clinical presentation, epidemiology, pathogenesis, histology, malignant transformation, and neurocutaneous melanosis. J Am Acad Dermatol. 2012;67:495.e1–17.CrossRefGoogle Scholar
  3. Barnhill RL, Barnhill MA, Berwick M, Mihm Jr MC. The histologic spectrum of pigmented spindle cell nevus: a review of 120 cases with emphasis on atypical variants. Hum Pathol. 1991;22:52–8.CrossRefGoogle Scholar
  4. Barnhill RL, Argenyi ZB, From L, et al. Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol. 1999;30:513–20.CrossRefGoogle Scholar
  5. Bett BJ. Large or multiple congenital melanocytic nevi: occurrence of cutaneous melanoma in 1008 persons. J Am Acad Dermatol. 2005;52:793–7.CrossRefGoogle Scholar
  6. Bevona C, Goggins W, Quinn T, Fullerton J, Tsao H. Cutaneous melanomas associated with nevi. Arch Dermatol. 2003;139:1620–4.CrossRefGoogle Scholar
  7. Casso EM, Grin-Jorgensen CM, Grant-Kels JM. Spitz nevi. J Am Acad Dermatol. 1992;27:901–13.CrossRefGoogle Scholar
  8. Celebi JT, Ward KM, Wanner M, Polsky D, Kopf AW. Evaluation of germline CDKN2A, ARF, CDK4, PTEN, and BRAF alterations in atypical mole syndrome. Clin Exp Dermatol. 2005;30:68–70.CrossRefGoogle Scholar
  9. Clarke LE. Dysplastic nevi. Clin Lab Med. 2011;31:255–65.CrossRefGoogle Scholar
  10. De Snoo FA, Kroon MW, Bergman W, ter Huurne JE, Houwing-Duistermaat JJ, van Mourik L, et al. From sporadic atypical nevi to familial melanoma: risk analysis for melanoma in sporadic atypical nevus patients. J Am Acad Dermatol. 2007;56:748–52.CrossRefGoogle Scholar
  11. DeDavid M, Orlow SJ, Provost N, et al. A study of large congenital melanocytic nevi and associated malignant melanomas: review of cases in the New York University Registry and the world literature. J Am Acad Dermatol. 1997;36:409–16.CrossRefGoogle Scholar
  12. Ferrara G, Argenziano G, Soyer HP, et al. The spectrum of Spitz nevi: a clinicopathologic study of 83 cases. Arch Dermatol. 2005;141:1381–7.CrossRefGoogle Scholar
  13. Gallagher RP, McLean DI. The epidemiology of acquired melanocytic nevi. A brief review. Dermatol Clin. 1995;13:595–603.CrossRefGoogle Scholar
  14. Gelbard SN, Tripp JM, Marghoob AA, et al. Management of Spitz nevi: a survey of dermatologists in the United States. J Am Acad Dermatol. 2002;47:224–30.CrossRefGoogle Scholar
  15. Geller AC, Swetter SM, Brooks K, Demierre MF, Yaroch AL. Screening, early detection, and trends for melanoma: current status (2000–2006) and future directions. J Am Acad Dermatol. 2007;57:555–72.CrossRefGoogle Scholar
  16. Haenssle HA, Korpas B, Hansen-Hagge C, Buhl T, Kaune KM, Johnsen S, Rosenberger A, Schön MP, Emmert S. Selection of patients for long-term surveillance with digital dermoscopy by assessment of melanoma risk factors. Arch Dermatol. 2010;146(3):257–64.CrossRefGoogle Scholar
  17. Harrison SL, MacLennan R, Buettner PG. Sun exposure and the incidence of melanocytic nevi in young Australian children. Cancer Epidemiol Biomarkers Prev. 2008;17:2318–24.CrossRefGoogle Scholar
  18. Ibrahimi OA, Alikhan A, Eisen DB. Congenital melanocytic nevi: where are we now? Part II. Treatment options and approach to treatment. J Am Acad Dermatol. 2012;67:515.e1–13.CrossRefGoogle Scholar
  19. Krengel S, Hauschild A, Schafer T. Melanoma risk in congenital melanocytic naevi: a systematic review. Br J Dermatol. 2006;155:1–8.CrossRefGoogle Scholar
  20. Lambert WC, Brodkin RH. Nodal and subcutaneous cellular blue nevi. A pseudometastasizing pseudomelanoma. Arch Dermatol. 1984;120:367–70.CrossRefGoogle Scholar
  21. Lovett A, Maari C, Decarie JC, et al. Large congenital melanocytic nevi and neurocutaneous melanocytosis: one pediatric center’s experience. J Am Acad Dermatol. 2009;61:766–74.CrossRefGoogle Scholar
  22. Marghoob AA, Schoenbach SP, Kopf AW, et al. Large congenital melanocytic nevi and the risk for the development of malignant melanoma. A prospective study. Arch Dermatol. 1996;132(2):170–5.CrossRefGoogle Scholar
  23. Marinkovic M, Janjic Z, Nikolic J. Dysplastic nevus–a risk factor of developing skin melanoma clinical and epidemiological study with retrospective review of literature. Med Pregl. 2011;64:315–8.CrossRefGoogle Scholar
  24. Menzies SW, Stevenson ML, Altamura D, Byth K. Variables predicting change in benign melanocytic nevi undergoing short-term dermoscopic imaging. Arch Dermatol. 2011;147(6):655–9.CrossRefGoogle Scholar
  25. Monteagudo B, Labandeira J, Acevedo A, et al. Prevalence and clinical features of congenital melanocytic nevi in 1,000 Spanish newborns. Actas Dermosifiliogr. 2011;102:114–20.CrossRefGoogle Scholar
  26. Murali R, McCarthy SW, Scolyer RA. Blue nevi and related lesions: a review highlighting atypical and newly described variants, distinguishing features and diagnostic pitfalls. Adv Anat Pathol. 2009;16:365–82.CrossRefGoogle Scholar
  27. Rodriguez HA, Ackerman LV. Cellular blue nevus. Clinicopathologic study of forty-five cases. Cancer. 1968;21:393–405.CrossRefGoogle Scholar
  28. Sepehr A, Chao E, Trefrey B, et al. Long-term outcome of Spitz-type melanocytic tumors. Arch Dermatol. 2011;147:1173–9.CrossRefGoogle Scholar
  29. Van Geel N, Vandenhaute S, Speeckaert R, et al. Prognostic value and clinical significance of halo naevi regarding vitiligo. Br J Dermatol. 2011;164:743–9.CrossRefGoogle Scholar
  30. Zaal LH, Mooi WJ, Klip H, van der Horst CM. Risk of malignant transformation of congenital melanocytic nevi: a retrospective nationwide study from The Netherlands. Plast Reconstr Surg. 2005;116:1902–9.CrossRefGoogle Scholar
  31. Zalaudek I, Schmid K, Marghoob AA, et al. Frequency of dermoscopic nevus subtypes by age and body site: a cross-sectional study. Arch Dermatol. 2011;147(6):663–70.CrossRefGoogle Scholar
  32. Zeff RA, Freitag A, Grin CM, Grant-Kels JM. The immune response in halo nevi. J Am Acad Dermatol. 1997;37:620–4.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Alexander C. Katoulis
    • 1
    Email author
  • Dimitrios Sgouros
    • 1
  • Nikolaos G. Stavrianeas
    • 2
  1. 1.2nd Department of Dermatology and VenereologyNational and Kapodistrian University of Athens Medical School, “Attikon” University HospitalAthensGreece
  2. 2.Professor Emeritus of Dermatology and VenereologyNational and Kapodistrian University of Athens Medical SchoolAthensGreece

Personalised recommendations